|
|
|
|
||
Re: IONS APOC III substandard to RNAi; dosing way too frequent.RNAi companies have made their investors a lot more over the past year. So unless you are just paid to fluff IONS, I don’t understand your point. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
61285 | Re: IONS APOC III substandard to RNAi; dosing way too frequent. | arthurs1 | 0 | 1/22/2020 5:33:00 PM |